Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -115.04x is 42% above its 1-year average of -199.91x, near the high end of its 1-year range (-284.79x–-115.04x).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-115.04x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-2.97x
median of 292 covered companies
CURRENT VS SECTOR MEDIAN
-3766.78%
vs the sector median at left
Avalyn Pharma Inc. Common Stock
Market Cap
$1.20B
Interest Coverage Ratio
-115.04x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.21B
Interest Coverage Ratio
N/A
TTM Avg
1.72x
3Y Avg
1.72x
5Y Avg
1.72x
Market Cap
$1.16B
Interest Coverage Ratio
2.05x
TTM Avg
1.65x
3Y Avg
1.11x
5Y Avg
0.98x
Market Cap
$1.24B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.14B
Interest Coverage Ratio
1.60x
TTM Avg
1.00x
3Y Avg
0.57x
5Y Avg
0.46x
Market Cap
$1.14B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.12B
Interest Coverage Ratio
-497.79x
TTM Avg
15.03x
3Y Avg
15.03x
5Y Avg
8.31x
Market Cap
$1.12B
Interest Coverage Ratio
5.51x
TTM Avg
6.14x
3Y Avg
19.44x
5Y Avg
31.00x
Market Cap
$1.33B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avalyn Pharma Inc. Common Stock (AVLN) | $1.20B | -115.04x | N/A | N/A | N/A |
| Cronos Group Inc. (CRON)vs › | $1.21B | N/A | 1.72x | 1.72x | 1.72x |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 2.05x | 1.65x | 1.11x | 0.98x |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.24B | N/A | N/A | N/A | N/A |
| Harrow Health, Inc. (HROW)vs › | $1.14B | 1.60x | 1.00x | 0.57x | 0.46x |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.14B | N/A | N/A | N/A | N/A |
| Castle Biosciences, Inc. (CSTL)vs › | $1.12B | -497.79x | 15.03x | 15.03x | 8.31x |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.12B | 5.51x | 6.14x | 19.44x | 31.00x |
| ArriVent BioPharma, Inc. (AVBP)vs › | $1.33B | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -13.34x | N/A | N/A | N/A |
Interest Coverage
-115.0x
Debt/Equity
0.04
Current Ratio
33.10
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -115.04x |
| 2026-03-31 | -284.79x |
